Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Modolo

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Annals of Cardiothoracic Surgery|August 11, 2018
SYNTAX II and SYNTAX III trials: what is the take home message for surgeons?Rodrigo Modolo, Carlos Collet, Yoshinobu Onuma, et al.
American Journal of Hypertension|November 30, 2017
Unsweetening the Heart: Possible Pleiotropic Effects of SGLT2 Inhibitors on Cardio and Cerebrovascular Alterations in Resistant Hypertensive SubjectsMariana R Pioli, Alessandra M V Ritter, Rodrigo Modolo
Current Hypertension Reports|August 21, 2014
Resistant or refractory hypertension: are they different?Rodrigo Modolo, Ana Paula de Faria, Aurélio Almeida, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2014
Adipokines: novel players in resistant hypertensionAna Paula de Faria, Rodrigo Modolo, Vanessa Fontana, et al.
Integrated Blood Pressure Control|December 7, 2018
White coat syndrome and its variations: differences and clinical impactMariana R Pioli, Alessandra Mv Ritter, Ana Paula de Faria, et al.
Vascular Health and Risk Management|October 31, 2017
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonistsJuan Carlos Yugar-Toledo, Rodrigo Modolo, Ana Paula de Faria, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 10, 2023
First results from the ACURATE Prime XL human feasibility studyRobert Gooley, Dale Murdoch, Martin K Ng, et al.
Arquivos Brasileiros De Cardiologia|October 30, 2014
Effects of PDE type 5 inhibitors on left ventricular diastolic dysfunction in resistant hypertensionAna Paula Cabral de Faria, Rodrigo Modolo, Beatriz Vaz Domingues Moreno, et al.
Blood Pressure|June 17, 2016
Effects of leptin and leptin receptor SNPs on clinical- and metabolic-related traits in apparent treatment-resistant hypertensionAna Paula de Faria, Alessandra M V Ritter, Andréa R Sabbatini, et al.
Journal of the American Society of Hypertension : JASH|May 17, 2015
Refractory and resistant hypertension: characteristics and differences observed in a specialized clinicRodrigo Modolo, Ana Paula de Faria, Andréa Rodrigues Sabbatini, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Annals of Cardiothoracic Surgery|August 11, 2018
SYNTAX II and SYNTAX III trials: what is the take home message for surgeons?Rodrigo Modolo, Carlos Collet, Yoshinobu Onuma, et al.
American Journal of Hypertension|November 30, 2017
Unsweetening the Heart: Possible Pleiotropic Effects of SGLT2 Inhibitors on Cardio and Cerebrovascular Alterations in Resistant Hypertensive SubjectsMariana R Pioli, Alessandra M V Ritter, Rodrigo Modolo
Current Hypertension Reports|August 21, 2014
Resistant or refractory hypertension: are they different?Rodrigo Modolo, Ana Paula de Faria, Aurélio Almeida, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2014
Adipokines: novel players in resistant hypertensionAna Paula de Faria, Rodrigo Modolo, Vanessa Fontana, et al.
Integrated Blood Pressure Control|December 7, 2018
White coat syndrome and its variations: differences and clinical impactMariana R Pioli, Alessandra Mv Ritter, Ana Paula de Faria, et al.
Vascular Health and Risk Management|October 31, 2017
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonistsJuan Carlos Yugar-Toledo, Rodrigo Modolo, Ana Paula de Faria, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 10, 2023
First results from the ACURATE Prime XL human feasibility studyRobert Gooley, Dale Murdoch, Martin K Ng, et al.
Arquivos Brasileiros De Cardiologia|October 30, 2014
Effects of PDE type 5 inhibitors on left ventricular diastolic dysfunction in resistant hypertensionAna Paula Cabral de Faria, Rodrigo Modolo, Beatriz Vaz Domingues Moreno, et al.
Blood Pressure|June 17, 2016
Effects of leptin and leptin receptor SNPs on clinical- and metabolic-related traits in apparent treatment-resistant hypertensionAna Paula de Faria, Alessandra M V Ritter, Andréa R Sabbatini, et al.
Journal of the American Society of Hypertension : JASH|May 17, 2015
Refractory and resistant hypertension: characteristics and differences observed in a specialized clinicRodrigo Modolo, Ana Paula de Faria, Andréa Rodrigues Sabbatini, et al.
Pageof 12